By Peter Loftus
President Trump's tariffs are eating into profits at GE Healthcare, the large maker of imaging and other medical equipment that was spun out of General Electric in 2023.
GE Healthcare reduced its forecast of full-year 2025 adjusted earnings by about 15% from its prior view, with U.S. and China bilateral tariffs accounting for most of the hit.
Yet, GE Healthcare shares are up about 3% Wednesday because investors already anticipated the tariff impact-trading the stock down year-to-date-and the company is taking actions to mitigate the hit.
The company also reported better-than-expected first-quarter results, analysts said.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
April 30, 2025 11:36 ET (15:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。